Biolog-id uses RFID technology to transform lifesaving and sensitive therapeutic products into connected devices, enhancing the management and traceability of products used in medical treatments.

Biolog-id

Biolog-id | 4,531 followers on LinkedIn. The smart healthcare solution for the management and traceability of sensitive health products. | Every public health organization is faced with the challenge of placing patients at the heart of their work and satisfying the demand for results.

Every year and all over the world, 108 million blood donations are collected, and almost 20 million new cases of cancer diagnosed. Given the growing and aging population with changing lifestyles, the need for blood and chemotherapy products will only continue to increase.

Ashraf Elsisy

Chief Operating Officer at Biolog-id

Bruno Chappert

Director, Data & Analytics at Biolog-id

David Jean-Baptiste, MS MIT

Regional Sales Manager at Biolog-id

Annalisa Starace

Biolog-id est à la recherche de son futur talent ! Toutes les informations se trouvent dans la fiche de poste ci-dessous. #customercare #santé #france #transfusion #oncologie

Biolog-id est fier de partager l’interview réalisée par le site d’information de la BPI avec le CEO de l’entreprise, qui décrit l’aventure de notre scale-up depuis bientôt 20 ans à travers ses défis quotidiens et son rayonnement à l’international. #transfusion #oncologie #santéconnectée #RFID #bloodbank #bloodmanagement #bloodcenter #ISBT #AABB

Biolog-id was pleased to attend the Global Health Exhibition from 21 to 23 October in Riyadh, Saudi. This year, through a presence on Algosaibi booth, it was a great opportunity to meet with some key people involved in transfusion and present our latest developments. #transfusion #innovation #healthcare #KSA #congress

SAVE THE DATE | #GERPAC2024 📅 Biolog-id sera présent au congrès GERPAC du 2 au 4 octobre à Hyères, pour vous présenter la solution C-LOG®. Nous serons ravis de vous accueillir au stand n°8 pour une démonstration. Au plaisir de tous vous y voir ! #congrès #oncologie #gerpac #santéconnectée

SAVE THE DATE | #TRANSMEDCON 2024 📅 Biolog-id is ready for TRANSMEDCON 2024 Mahabalipuram in India! We are delighted to attend the Annual National Conference of Indian Society of Transfusion Medicine and share with you the latest developments in our Blood Transfusion solution. Come and visit us at booth n°24 & 38. We can’t wait to see you! #congress #bloodtransfusion #healthcare #healthconnected

Biolog-id was at International Society of Blood Transfusion (ISBT) in Barcelona! This was an opportunity to see our customers, who continue to show increasing interest in the Biolog transfusion solution. It was also a pleasure to meet many prospects, who asked for demonstrations of the Smart Access Kit, Biolog-id's latest innovation. #transfusion #innovation #healthcare #connectedhealth #ISBT #internationalcongress

SAVE THE DATE | #ISBT 📅 Biolog-id is ready for International Society of Blood Transfusion (ISBT) 2024 in Barcelona! We are happy to attend the ISBT congress and share with you the latest developments in our Blood Transfusion solution. Come and visit us at booth N°A24. We can’t wait to meeting you! #congress #ISBT #bloodtransfusion #connectedhealth

Metric
Company Name	Biolog-id
Symbol
MSH ID	COM:BIOLOG-ID
Market	PRIVATE
Sector	Healthcare & Health Services
Industry	Medical Devices
Country	FR
Stage	Venture Round
Employee Count
Website	biolog-id.com
LinkedIn	biolog-id
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic	671
Web Traffic Growth	2.31
Valuation
Raised Capital	25M

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

BIOL

COM:BIOLOG-ID

Biolog-id

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue